Post by Helmut Haning

Based on our unique phenotypic screening capabilities, we have discovered a novel mechanism to potentially treat a-synucleinopathies in Parkinsons disease. We have unravelled the molecular target and are now in early leadoptimization. Now we are seeking funding to drive this drug discovery project towards IND. Interested in a novel mechanism for PD treatment? Come speak to us